TNF and tuberculosis: Thus, there is an enormous reservoir of potential sources of TB transmission (2 billion people), and therefore prevention of endogenous reactivation in high risk subjects (e.g., elderly, HIV positive or malnourished individuals, patients undergoing anti-TNF therapy) is strategic for control of global disease burden.